Loading…
IDEXX Laboratories, Inc. is projected to rise to $627.98 by 2027, a +11% move from its current price of $563.57. IDXX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $554.18 | $563.59 | $573.16 | 0.00% |
| Jul 13 | $550.35 | $563.61 | $577.20 | +0.01% |
| Jul 14 | $547.44 | $563.64 | $580.32 | +0.01% |
| Jul 15 | $544.99 | $563.66 | $582.96 | +0.02% |
| Jul 16 | $542.85 | $563.68 | $585.31 | +0.02% |
| Jul 17 | $540.93 | $563.70 | $587.44 | +0.02% |
| Jul 18 | $539.16 | $563.72 | $589.40 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $539.16 | $563.72 | $589.40 | +0.03% |
| Week 2 | $529.45 | $563.88 | $600.55 | +0.05% |
| Week 3 | $522.15 | $564.03 | $609.28 | +0.08% |
| Week 4 | $516.10 | $564.19 | $616.76 | +0.11% |
| Week 5 | $510.84 | $564.35 | $623.45 | +0.14% |
| Week 6 | $506.15 | $564.50 | $629.58 | +0.17% |
| Week 7 | $501.88 | $564.66 | $635.29 | +0.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IDEXX Laboratories, Inc. is a healthcare company that develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups.
In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.
IDEXX Laboratories, Inc. (IDXX) trades in the Healthcare sector with a current price of $562.09 and a market capitalization of $44.34B. It is ranked 344 by market cap in the current landscape.
The stock trades near the 50-day simple moving average of $561.85 and remains below the 200-day simple moving average of $632.52, indicating proximity to near-term momentum levels.
Over the last 30 days, the price has fluctuated between $498.91 and $633.27, illustrating a relatively wide trading range. The price trajectory and nearby moving averages frame an overall positive outlook, supported by a long-run forecast showing rising averages and increasingly favorable returns through 2050, starting from the current level of $562.09.
A major floor 10.6% below — a decisive break under it would weaken the trend.
The nearest floor, 6.6% below — buyers have tended to step in here.
Price is pressing into resistance (2.7% away) — a breakout level to watch.
A major ceiling 15.1% above — clearing it would confirm fresh momentum.
Key IDXX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IDXX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $562.61 | Buy | $559.64 | Buy |
| MA 10 | $552.23 | Buy | $556.59 | Buy |
| MA 20 | $554.17 | Buy | $555.41 | Buy |
| MA 50 | $555.19 | Buy | $560.55 | Buy |
| MA 100 | $574.44 | Sell | $577.65 | Sell |
| MA 200 | $625.90 | Sell | $589.35 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.27 | Neutral |
| Stoch RSI (14) | 83.46 | Sell |
| CCI (20) | 62.89 | Neutral |
| Williams %R (14) | -15.25 | Info |
| MACD (12,26,9) | 1.93 | Buy |
| ROC (12) | 4.11 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 84.75 | Sell |
| TRIX (15) | -0.04 | Sell |
| Awesome (5,34) | 5.62 | Buy |
| Ultimate (7,14,28) | 66.17 | Neutral |
| Momentum (10) | 8.63 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 565.87 | Sell |
| ADX (14) | 8.20 | Neutral |
| ATR (14) | 9.17 | Info |
Technical picture for the last 30 days shows bullish sentiment overall. The RSI(14) is 50, indicating a neutral momentum reading near the midpoint.
The stock sits close to the SMA50 of $561.85, with the SMA200 at $632.52 providing a longer-term benchmark. Immediate support is at $528.68 and resistance at $578.89, framing a modest short-term trading channel.
The 30-day trading range extends from $498.91 to $633.27, reflecting a broad swing in near-term price action.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $526.44 | $563.57 | $692.43 | 0% | Neutral | |
| $514.30 | $627.98 | $801.70 | +11% | Neutral | |
| $607.99 | $756.32 | $991.65 | +34% | Bullish | |
| $663.50 | $838.10 | $1,122.27 | +49% | Bullish | |
| $727.91 | $931.89 | $1,270.31 | +65% | Bullish | |
| $748.49 | $969.93 | $1,343.07 | +72% | Bullish | |
| $753.48 | $987.42 | $1,386.74 | +75% | Bullish | |
| $829.81 | $1,098.91 | $1,563.29 | +95% | Bullish | |
| $858.67 | $1,148.44 | $1,653.27 | +104% | Bullish | |
| $973.56 | $1,314.43 | $1,913.28 | +133% | Bullish | |
| $1,224.55 | $1,724.37 | $2,630.34 | +206% | Bullish | |
| $2,294.45 | $3,465.18 | $5,665.93 | +515% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $526.44 | $563.57 | $668.29 | +0.00% |
| August 2026 | $476.71 | $558.08 | $667.55 | -0.97% |
| September 2026 | $480.82 | $565.59 | $681.78 | +1.35% |
| October 2026 | $489.25 | $577.86 | $701.15 | +2.17% |
| November 2026 | $481.58 | $570.77 | $696.36 | -1.23% |
| December 2026 | $474.91 | $564.68 | $692.43 | -1.07% |
Click any year to see its month-by-month IDXX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, IDXX could reach as high as $692.43, with a base case around $563.57 and support toward $526.44 — roughly 0% from $563.57. Price action looks broadly range-bound.
Expect IDXX to range from $514.30 to $801.70 through 2027. The $627.98 average target implies a +11% move from current prices. That is up +11% on the projected 2026 average. A consolidation phase looks the most probable path here.
The IDXX price prediction for 2028 points to an average of $756.32 (low $607.99, high $991.65) — a potential gain of +34% on today's $563.57. Momentum favours further upside here.
In 2029, IDXX is projected to trade between $663.50 and $1,122.27, averaging $838.10 — a potential gain of +49% from today's $563.57. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
IDEXX Laboratories, Inc.'s 2030 outlook centres on $931.89, within a $727.91 to $1,270.31 range. That is up +11% on the projected 2029 average. That marks a +65% change versus current levels. Momentum favours further upside here.
By 2031, IDXX could reach as high as $1,343.07, with a base case around $969.93 and support toward $748.49 — roughly +72% from $563.57. Buyers look set to stay in control over this stretch.
Expect IDXX to range from $753.48 to $1,386.74 through 2032. The $987.42 average target implies a +75% move from current prices. That is up +2% on the projected 2031 average. Momentum favours further upside here.
The IDXX price prediction for 2033 points to an average of $1,098.91 (low $829.81, high $1,563.29) — a potential gain of +95% on today's $563.57. Buyers look set to stay in control over this stretch.
In 2034, IDXX is projected to trade between $858.67 and $1,653.27, averaging $1,148.44 — a potential gain of +104% from today's $563.57. That is up +5% on the projected 2033 average. Momentum favours further upside here.
IDEXX Laboratories, Inc.'s 2035 outlook centres on $1,314.43, within a $973.56 to $1,913.28 range. That is up +14% on the projected 2034 average. That marks a +133% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, IDXX could reach as high as $2,630.34, with a base case around $1,724.37 and support toward $1,224.55 — roughly +206% from $563.57. Momentum favours further upside here.
Expect IDXX to range from $2,294.45 to $5,665.93 through 2050. The $3,465.18 average target implies a +515% move from current prices. That is up +101% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in IDXX today (≈ 1.774402 IDXX) could be worth
$6,148.63
+$5,148.63 (+515%) by 2050 · US Dollar
Based on the average projected IDXX price of $3,465.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IDXXwould be worth at today's price.
$1,000 invested in IDXX on Jul 10, 2025 (≈ 1.848121 IDXX) would be worth
$1,041.55
+$41.55 (+4.2%) today · 1.04× · US Dollar
Based on a IDXX entry price of $541.09 vs. today's $563.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $557.8 | $1,010.34 | +1.0% |
| 1 month ago | $556.94 | $1,011.9 | +1.2% |
| 3 months ago | $563 | $1,001.01 | +0.1% |
| 6 months ago | $724.76 | $777.6 | -22.2% |
| 1 year ago | $541.09 | $1,041.55 | +4.2% |
| All time (5.0y) ago | $659.54 | $854.49 | -14.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IDXX forecast.
Our base-case forecast reaches $1,100.00 around 2034.
Implied market cap at $1,100.00: $86.77B
The multi-year forecast lays out a bullish path with rising averages and higher ROIs across the years. The 2026 forecast shows a min of $528.68, an avg of $562.09, and a max of $701.38, with an ROI of 0 and a Neutral sentiment.
In 2027, the avg rises to $630.06 (min $515.44, max $805.63) and the ROI is 12.1%, with Neutral sentiment. The trajectory strengthens through 2028 (avg $748.87, min $601.48, max $983.06; ROI 33.2%), 2029 (avg $839.77, min $664.33, max $1,125.62; ROI 49.4%), and 2030 (avg $920.05, min $718.19, max $1,255.26; ROI 63.7%), all with a bullish orientation.
Continuing growth appears in 2031 (avg $952.98; min $734.97; max $1,320.62; ROI 69.5%), 2032 (avg $987.42; min $753.05; max $1,387.71; ROI 75.7%), 2033 (avg $1,080.48; min $815.46; max $1,538.05; ROI 92.2%), 2034 (avg $1,120.13; min $837.08; max $1,613.47; ROI 99.3%), and 2035 (avg $1,311.89; min $971.22; max $1,910.65; ROI 133.4%).
The forecast shows further upside into 2040 (avg $1,673.54; min $1,187.97; max $2,553.90; ROI 197.7%) and 2050 (avg $3,425.55; min $2,267.45; max $5,602.85; ROI 509.4%), with sentiment remaining BULLISH. These figures are estimates and not guarantees, reflecting potential upside under favorable conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $920.05, with a min of $718.19 and a max of $1,255.26. The ROI is 63.7%, and the sentiment is BULLISH.
The forecast includes a neutral stance in 2026 (avg $562.09, ROI 0) with a transition to bullish momentum in following years (e.g., 2027 avg $630.06, ROI 12.1; 2028 avg $748.87, ROI 33.2; 2029 avg $839.77, ROI 49.4; 2030 avg $920.05, ROI 63.7). Overall, the outlook moves toward higher averages and ROIs with a bullish sentiment in later years.
Yes. The 2050 forecast lists a max of $5,602.85, with an avg of $3,425.55 and a min of $2,267.45 in that year.
The current price is $562.09 and the market cap is $44.34B.
RSI(14) is 50. The SMA50 is $561.85 and the SMA200 is $632.52. Support is at $528.68 and resistance at $578.89. The 30-day trading range is $498.91 to $633.27, and the sentiment is BULLISH.
IDEXX Laboratories, Inc. Community Discussion
0Share your IDEXX Laboratories, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.